These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 19892878)
1. Characterizing the involvement of the nuclear factor-kappa B (NF kappa B) transcription factor in uveal melanoma. Dror R; Lederman M; Umezawa K; Barak V; Pe'er J; Chowers I Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):1811-6. PubMed ID: 19892878 [TBL] [Abstract][Full Text] [Related]
2. Inhibitor of apoptosis proteins gene expression and its correlation with prognostic factors in primary and metastatic uveal melanoma. Lederman M; Meir T; Zeschnigk M; Pe'er J; Chowers I Curr Eye Res; 2008 Oct; 33(10):876-84. PubMed ID: 18853322 [TBL] [Abstract][Full Text] [Related]
4. SPARC is expressed in human uveal melanoma and its abrogation reduces tumor cell proliferation. Maloney SC; Marshall JC; Antecka E; Orellana ME; Fernandes BF; Martins C; Castiglione E; DI Cesare S; Logan P; Burnier MN Anticancer Res; 2009 Aug; 29(8):3059-64. PubMed ID: 19661316 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of chemokine receptors on uveal melanoma cells and their metastases. Li H; Alizadeh H; Niederkorn JY Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):636-43. PubMed ID: 18235009 [TBL] [Abstract][Full Text] [Related]
6. Antitumor effects of dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, in human liver cancer cells are mediated through a reactive oxygen species-dependent mechanism. Lampiasi N; Azzolina A; D'Alessandro N; Umezawa K; McCubrey JA; Montalto G; Cervello M Mol Pharmacol; 2009 Aug; 76(2):290-300. PubMed ID: 19461054 [TBL] [Abstract][Full Text] [Related]
7. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK. Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225 [TBL] [Abstract][Full Text] [Related]
8. The role of RASSF1A in uveal melanoma. Dratviman-Storobinsky O; Cohen Y; Frenkel S; Merhavi-Shoham E; El SD; Binkovsky N; Pe'er J; Goldenberg-Cohen N Invest Ophthalmol Vis Sci; 2012 Oct; 53(6):2611-9. PubMed ID: 22447862 [TBL] [Abstract][Full Text] [Related]
9. Molecular characteristics of liver metastases from uveal melanoma. Meir T; Dror R; Yu X; Qian J; Simon I; Pe'er J; Chowers I Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4890-6. PubMed ID: 17962435 [TBL] [Abstract][Full Text] [Related]
10. Induction of thyroid cancer cell apoptosis by a novel nuclear factor kappaB inhibitor, dehydroxymethylepoxyquinomicin. Starenki DV; Namba H; Saenko VA; Ohtsuru A; Maeda S; Umezawa K; Yamashita S Clin Cancer Res; 2004 Oct; 10(20):6821-9. PubMed ID: 15501958 [TBL] [Abstract][Full Text] [Related]
11. Modulation of TNF-alpha-induced apoptosis in corneal fibroblasts by transcription factor NF-kappaB. Mohan RR; Mohan RR; Kim WJ; Wilson SE Invest Ophthalmol Vis Sci; 2000 May; 41(6):1327-36. PubMed ID: 10798647 [TBL] [Abstract][Full Text] [Related]
12. c-Met, epidermal growth factor receptor, and insulin-like growth factor-1 receptor are important for growth in uveal melanoma and independently contribute to migration and metastatic potential. Wu X; Zhou J; Rogers AM; Jänne PA; Benedettini E; Loda M; Hodi FS Melanoma Res; 2012 Apr; 22(2):123-32. PubMed ID: 22343486 [TBL] [Abstract][Full Text] [Related]
13. Expression of the metastasis suppressor gene KISS1 in uveal melanoma. Martins CM; Fernandes BF; Antecka E; Di Cesare S; Mansure JJ; Marshall JC; Burnier MN Eye (Lond); 2008 May; 22(5):707-11. PubMed ID: 18219339 [TBL] [Abstract][Full Text] [Related]
14. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway. Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226 [TBL] [Abstract][Full Text] [Related]
15. MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment. Bérubé M; Deschambeault A; Boucher M; Germain L; Petitclerc E; Guérin SL Mol Vis; 2005 Dec; 11():1101-11. PubMed ID: 16379022 [TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target. All-Ericsson C; Girnita L; Seregard S; Bartolazzi A; Jager MJ; Larsson O Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):1-8. PubMed ID: 11773005 [TBL] [Abstract][Full Text] [Related]
17. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type. Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742 [TBL] [Abstract][Full Text] [Related]
18. Apoptosis inhibitor, survivin, in posterior uveal melanoma: comparison among primary tumors, tumors resistant to brachytherapy, tumors with liver metastases, and liver metastases. Ben Simon GJ; Abulafia A; Pe'er J Curr Eye Res; 2006 Mar; 31(3):251-7. PubMed ID: 16531282 [TBL] [Abstract][Full Text] [Related]
19. Caspase-8-mediated apoptosis in human RPE cells. Yang P; Peairs JJ; Tano R; Zhang N; Tyrell J; Jaffe GJ Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3341-9. PubMed ID: 17591907 [TBL] [Abstract][Full Text] [Related]
20. Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines. Klisovic DD; Katz SE; Effron D; Klisovic MI; Wickham J; Parthun MR; Guimond M; Marcucci G Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2390-8. PubMed ID: 12766035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]